Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
12/1998
12/10/1998WO1998055613A1 Zinc ring protein
12/10/1998WO1998055607A2 Tumor targeted vector
12/10/1998WO1998055600A2 New human ribonuclease
12/10/1998WO1998055511A1 Novel canine cytokine protein
12/10/1998WO1998055510A2 Human ubiquitin carrier protein e2-like protein and cyclin b-like protein
12/10/1998WO1998055507A2 Modulators of intracellular inflammation, cell death and cell survival pathways containing a card and kinase domain
12/10/1998WO1998055151A1 Box-dependent myc-interacting protein (bin1) compositions and uses therefor
12/10/1998WO1998055150A1 Txu-7-pap immunotoxin and use thereof
12/10/1998WO1998055146A1 IDENTIFICATION OF HUMAN HEAVY CHAIN ANTIBODY FRAGMENT DIRECTED AGAINST HUMAN PLATELET ALLOANTIGEN 1a(HPA-1a)
12/10/1998WO1998055143A1 Lipid-reduced oral formulation for egg yolk-derived therapeutic protein
12/10/1998WO1998055139A1 Use of leptin antagonists for the treatment of diabetes
12/10/1998WO1998055132A1 Prion protein modulator factor (ppmf) and prion resistant animals
12/10/1998WO1998047343A3 Antibodies or binding protein libraries displayed on phage, cells, or other replicatable genetic packages
12/10/1998WO1998040497A3 An ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in said method
12/10/1998WO1998039429A3 Compositions for treatment of disorders involving programmed cell death
12/10/1998WO1998036059A3 Prion propagation inhibition by dominant-negative prion protein mutants
12/10/1998WO1998035236A3 Immunological assay for spongiform encephalopathies
12/10/1998WO1998022575A3 Nucleotide sequence of escherichia coli pathogenicity islands
12/10/1998CA2293693A1 Anti-gpiib/iiia recombinant antibodies
12/10/1998CA2293504A1 Use of leptin antagonists for the treatment of diabetes
12/10/1998CA2292899A1 Ntn-2 member of tnf ligand family
12/10/1998CA2292892A1 Translational regulator initiation factor 4e-binding protein
12/10/1998CA2292891A1 Zinc ring protein
12/10/1998CA2292840A1 Mitofusin genes and their uses
12/10/1998CA2292835A1 Ntn-2 member of tnf ligand family
12/10/1998CA2292764A1 Method of detecting thrombotic disease risk
12/10/1998CA2292760A1 Vector
12/10/1998CA2292759A1 Reagents and methods useful for detecting diseases of the urinary tract
12/10/1998CA2292643A1 Human ubiquitin carrier protein e2-like protein and cyclin b-like protein
12/10/1998CA2292426A1 Txu-7-pap immunotoxin and use thereof
12/10/1998CA2291661A1 New human ribonuclease
12/10/1998CA2289479A1 Modulators of intracellular inflammation, cell death and cell survival pathways containing a card and kinase domain
12/10/1998CA2287848A1 Prion protein modulator factor (ppmf) and prion resistant animals
12/10/1998CA2234411A1 Novel compounds
12/09/1998EP0882799A1 ANTI-HUMAN VEGF RECEPTOR F1t-1 MONOCLONAL ANTIBODY
12/09/1998EP0882796A2 Nucleic acid molecules encoding Streptococcus pneumoniae rnc protein, and compositions comprising the same
12/09/1998EP0882795A2 Recombinant secA1 polypeptides from Staphylococcus aureus and uses thereof
12/09/1998EP0882794A2 Human complementarity determining region (CDR)-grafted antibody to ganglioside gm2
12/09/1998EP0882793A2 A human 7-tm receptor similar to murine frizzled-6 gene
12/09/1998EP0882791A2 WNT-11 polypeptides
12/09/1998EP0882130A2 Human cancer antigen of tyrosinase-related protein 1 and 2 and genes encoding same
12/09/1998EP0882067A2 Methods of treating vascular disease with tnf antagonists
12/09/1998EP0882065A2 Novel human metabotropic glutamate receptor
12/09/1998EP0882060A1 Parasitic helminth macrophage migration inhibitory factor proteins, nucleic acid molecules, and uses thereof
12/09/1998EP0881910A1 Use of immunoconjugates to enhance the efficacy of multi-stage cascade boosting vaccines
12/09/1998EP0776338B1 Immunoconjugates comprising tyrosine kinase inhibitors
12/09/1998EP0689599B1 Chimeric selectins by exchange of domains - uses thereof
12/09/1998CN1201492A Cell-cycle checkpoint genes
12/09/1998CA2231015A1 Novel compounds
12/08/1998US5847099 TNF receptor death domain ligand proteins
12/08/1998US5847093 Human apoptosis regulator
12/08/1998US5847088 Antibodies specific for platelet-activating factor acetylhydrolase
12/08/1998US5847007 Prevention and treatment of pathologies associated with abnormally proliferative smooth muscle cells
12/08/1998US5846948 Herpes simplex virus ORF P is a repressor of viral protein synthesis
12/08/1998US5846825 Feline derived T-cell lines for producing FIV
12/08/1998US5846821 Metal-regulated transporters and uses therefor
12/08/1998US5846818 Pectate lyase signal sequence
12/08/1998US5846805 Culture of swine infertility and respiratory syndrome virus in simian cells
12/08/1998US5846800 Nucleic acid molecules encoding a novel receptor-type protein tyrosine phosphatase-σ
12/08/1998US5846779 Nucleic acids encoding murine UCP3 genes
12/08/1998US5846772 Two component signal transduction system response regulator polynucleotides of Staphylococcus aureus
12/08/1998US5846764 Materials and methods relating to proteins that interact with casein kinase I
12/08/1998US5846746 Antibody to ocular and vaginal surface epithelium
12/08/1998US5846740 Methods and kits useful for detecting autoantibody to glutamic acid decarboxylase
12/08/1998US5846735 Hepatitis C virus Fc-binding function
12/08/1998US5846734 Mammalian adipogenic factors
12/08/1998US5846732 Peptides of caseinomacropeptide, antibodies against the said peptides, and uses
12/08/1998US5846725 Methods for identifying cisplatin resistant tumor cells
12/08/1998US5846712 Tumor suppressor gene, HIC-1
12/08/1998US5846538 Immune reactivity to HER-2/neu protein for diagnosis and treatment of malignancies in which the her-2/neu oncogene is associated
12/08/1998US5846536 Restoration of normal phenotype in cancer cells
12/08/1998US5846535 Methods for reducing tumor cell growth by using antibodies with broad tumor reactivity and limited normal tissue reactivity
12/08/1998US5846534 Antibodies to the antigen campath-1
12/08/1998US5846533 Antibodies specific for native PrPSc
12/08/1998CA2066612C Method of producing fusion proteins
12/05/1998CA2233591A1 Novel compounds
12/04/1998CA2233590A1 Novel compounds
12/04/1998CA2233587A1 Novel compounds
12/03/1998WO1998054577A1 Cyclic peptide libraries and methods of use thereof to identify binding motifs
12/03/1998WO1998054348A1 Telomere-associated chromosome fragmentation
12/03/1998WO1998054322A1 Osf2/cbfa1 compositions and methods of use
12/03/1998WO1998054321A1 New human dp1 homolog
12/03/1998WO1998054318A1 TUMOUR SUPPRESSOR GENE DBCCR1 AT 9q32-33
12/03/1998WO1998054316A1 Sodium channel receptor
12/03/1998WO1998054312A1 Ribosome complexes as selection particles for in vitro display and evolution of proteins
12/03/1998WO1998054226A1 Processes for production of immunoglobulin a in milk
12/03/1998WO1998054225A2 Human-cd28 specific monoclonal antibodies for antigen non-specific activation of t-lymphocytes
12/03/1998WO1998054220A1 PGC-1, A NOVEL BROWN FAT PPARη COACTIVATOR
12/03/1998WO1998054209A2 Human mast cell function-associated antigen (mafa) and uses thereof
12/03/1998WO1998054206A1 32 human secreted proteins
12/03/1998WO1998054202A1 Human tumor necrosis factor receptor tr10
12/03/1998WO1998053843A1 INHIBITION OF ANTIGEN-SPECIFIC IgE PRODUCTION BY ANTIGEN COUPLED TO MEMBRANE IgE PETIDE
12/03/1998WO1998053840A1 SIALOADHESIN FAMILY 4 cDNA
12/03/1998WO1998053838A2 A soluble laminin receptor precursor and methods to inhibit its interactions
12/03/1998WO1998045332A3 Humanized antibodies and methods for forming humanized antibodies
12/03/1998WO1998045331A3 Anti-vegf antibodies
12/03/1998WO1998041238A3 Methods and kits for treating and diagnosing leiomyomas
12/03/1998WO1998039440A3 CALCIUM INDEPENDENT RECEPTOR OF α-LATROTOXIN, CHARACTERIZATION AND USES THEREOF
12/03/1998DE19722888A1 Human-CD28 spezifische monoklonale Antikörper zur antigenunspezifischen Aktivierung von T-Lymphozyten Human CD28 specific monoclonal antibodies for the antigen non-specific activation of T-lymphocytes
12/03/1998DE19719652A1 Use of tissue factor
1 ... 1249 1250 1251 1252 1253 1254 1255 1256 1257 1258 1259 1260 1261 1262 1263 1264 1265 1266 1267 1268 1269 ... 1494